Verastem (VSTM) Capital Expenditures (2011 - 2024)

Verastem (VSTM) recorded quarterly Capital Expenditures of $7000.0 in Q2 2024, down 66.67% quarter-over-quarter from $21000.0 in Q1 2024.

Verastem (VSTM) Capital Expenditures (2011 - 2024) Analysis & Trends

Verastem's Capital Expenditures history runs 9 years deep, the most recent figure standing at $7000.0 for Q2 2024.

  • In Q2 2024, Capital Expenditures changed N/A year-over-year to $7000.0; the TTM figure through Dec 2024 stood at $28000.0 (changed N/A YoY), while the FY2024 annual figure was $28000.0, up 300.0% from the prior year.
  • Capital Expenditures was $7000.0 for Q2 2024 at Verastem, down from $21000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $211000.0 in Q3 2020 to a low of -$7000.0 in Q2 2020.
  • Historically, Capital Expenditures has averaged $73500.0 across 3 years, with a median of $17000.0 in 2020.
  • Biggest YoY gain for Capital Expenditures was 1407.69% in 2021; the steepest drop was 1407.69% in 2021.
  • A 3-year view of Capital Expenditures shows it stood at $211000.0 in 2020, then retreated by 7.11% to $196000.0 in 2021, then tumbled by 96.43% to $7000.0 in 2024.
  • The last three Capital Expenditures figures came in at $7000.0 (Q2 2024), $21000.0 (Q1 2024), and $196000.0 (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 7,000.00
Jun 30, 2024 7,000.00
Mar 31, 2024 21,000.00
Mar 31, 2024 21,000.00
Mar 31, 2021 196,000.00
Mar 31, 2021 196,000.00
Sep 30, 2020 211,000.00
Sep 30, 2020 211,000.00
Jun 30, 2020 -7,000.00
Jun 30, 2020 -7,000.00
Mar 31, 2020 13,000.00
Mar 31, 2020 13,000.00
Dec 31, 2018 263,000.00
Dec 31, 2018 263,000.00
Sep 30, 2018 717,000.00
Sep 30, 2018 717,000.00
Jun 30, 2018 425,000.00
Jun 30, 2018 425,000.00
Mar 31, 2018 102,000.00
Mar 31, 2018 102,000.00